Elsa Arribas, M.D.
Department of Breast Imaging, Division of Diagnostic Imaging
About Dr. Arribas
Elsa Arribas, M.D. came to the University of Texas MD Anderson Cancer Center as a fellow in 2000 and joined the Section of Breast Imaging as a faculty member in 2001. Dr. Arribas is currently the chair of the Interesting Case Conference and Clinical Effort Management Committee. Recent abstracts presented at the Radiological Society of North America include: Giant Breast Masses: Differential Diagnosis with Multimodality and Histopathology Correlation; Manifestation of Hematologic Diseases in the Breast: Multimodality Review with Pathologic Correlation; and Primary Lymphoma of the Breast: Multimodality Features with Pathologic Correlation and Management Review. Dr. Arribas is dedicated to the continuous effort to Making Cancer History.
Read More
Present Title & Affiliation
Primary Appointment
Professor, Department of Breast Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Screening Breast Ultrasound in High-Risk Women
Clinical Interests
Minimally Invasive Procedures
Breast Cancer Screening and Staging
Education & Training
Degree-Granting Education
| 1996 | University of Puerto Rico, San Juan, PRI, MD, Medicine |
| 1992 | University of Puerto Rico, Rio Piedras, PRI, BS, Medical |
Postgraduate Training
| 2000-2001 | Clinical Fellowship, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1996-2000 | Clinical Residency, Radiology, The University of Texas Medical School, Houston, TX |
Board Certifications
| 2000 | American Board of Radiology |
Experience & Service
Academic Appointments
Associate Professor, Department of Breast Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2020
Associate Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2019
Assistant Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2010
Administrative Appointments/Responsibilities
Quality Assurance Officer for Breast Imaging Section, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2012
Institutional Committee Activities
Member, Division of Diagnostic Imaging Council on Gender Inclusiveness, 2013 - Present
Selected Publications
Peer-Reviewed Articles
- Santiago L, Adrada B, Caudle A, Clemens M, Black D, Arribas E. The role of 3-dimensional printing in the surgical management of breast cancer. Journal of Surgical Oncology DOI: 10.1002/jso.25680, 2019. PMID: 31441070.
- Candelaria RP, Adrada BE, Wei W, Thompson AM, Santiago L, Lane DL, Huang ML, Arribas EM, Rauch GM, Fraser Symmans W, Gilcrease MZ, Huo L, Lim B, Ueno NT, Moulder SL, Yang WT.. Imaging features of triple-negative breast cancers according to androgen receptor status. European Journal of Radiology 114:167-174, 2019. PMID: 31005169.
- Haygood TM, Arribas E, Liu QM, Atkinson EN, Brennan PC, Santiago L, Carkaci S, Lane D, Stephens TW, Le-Petross H, Adrada B, Davis P, Whitman GJ. Detection of microcalcifications on digital screening mammograms using varying degrees of monitor zooming. American Journal of Roentgenology 197(4):W761-8, 2011. PMID: 21940549.
- Resetkova E, Khazai L, Albarracin CT, Arribas E. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast. The Breast Journal 16(6):573-80, 2010. PMID: 21070433.
- Tchou PM, Haygood TM, Atkinson EN, Stephens TW, Davis PL, Arribas E, Geiser WR, Whitman GJ. Interpretation time of computer-aided detection at screening mammography. Radiology 257(1):40-6, 2010. e-Pub 2010. PMID: 20679448.
- Adrada B, Arribas E, Gilcrease M, Yang WT. Invasive micropapillary carcinoma of the breast: Mammographic, sonographic, and MRI features. American Journal of Roentgenology 193(1):W58-63, 2009. PMID: 19542384.
- Lai CJ, Shaw CC, Geiser W, Chen L, Arribas E, Stephens T, Davis PL, Ayyar GP, Dogan BE, Nguyen VA, Whitman GJ, Yang WT. Comparison of slot scanning digital mammography system with full-field digital mammography system. Medical Physics 35(6):2339-46, 2008. PMID: 18649467.
- Lai CJ, Shaw CC, Whitman GJ, Johnston DA, Yang WT, Selinko V, Arribas E, Dogan B, Kappadath SC. Visibility of simulated microcalcifications--a hardcopy-based comparison of three mammographic systems. Medical Physics 32(1):182-94, 2005. PMID: 15719969.
- Lutzker S, Le V, Perez-Young I, Arribas E, Ernst R, Kawashima A, Sandler C. A desktop digital imaging and communications in medicine picture archiving and communications system with multiple monitors using Windows '98. Journal of Digital Imaging 12(2 Suppl 1):191, 1999. PMID: 10342208.
- Carr LW, Roberts J, Mericli AF, Liu J, Arribas EM, Clemens MW. Breast implant imaging surveillance among US plastic surgeons: FDA recommendations versus clinical reality. Plastic and Reconstructive Surgery 145(6):1381-1387. e-Pub 2020.
Invited Articles
- Whitman GJ, Arribas E, Uppendahl L. Mammographic-sonographic correlation. Semin Roentgenol 46(4):252-9, 2011. PMID: 22035667.
Manuals, Teaching Aids, Other Teaching Publications
- Albarracin C, Araujo D, Arribas E, Arun B, Babiera G, Bast R, Bedrosian I, Benjamin R, Black S, Booser D, et al.. Practice algorithm for phyllodes tumor: Houston, TX, 2019.
- Moseley TW, Adrada BE, Arribas EM. Breast cancer noninvasive- documents for clinical scenario appropriate use criteria/ qualified provider-led entity: Houston, TX, 2019.
- Moseley TW, Adrada BE, Arribas EM. Phyllodes tumors- documents for clinical scenario appropriate use criteria/ qualified provider-led entity: Houston, TX, 2019.
- Abouharb S, Adrada B, Akay C, Albarracin C, Arribas E, Arun B, Barcenas C, Bast R, Bedrosian I, Booser D, et al.. Practice algorithm for breast cancer – invasive: Houston, TX, 2018.
- Albarracin C, Ames F, Andreopoulo E, Araujo D, Arribas E, Arun B, Babiera G, Bast R, Bedrosian I, Benjamin R, et al.. Practice algorithm for phyllodes tumor: Houston, TX, 2017.
- Abouharb S, Adrada B, Albarracin C, Arribas E, Arun B, Barcenas C, Bast R, Babiera G, Bedrosian I, Booser D, et al.. Practice algorithm for breast cancer – noninvasive: Houston, TX, 2017.
- Albarracin C, Ames F, Andreopoulo E, Araujo D, Arribas E, Arun B, Babiera G, Bast R, Bedrosian I, Benjamin R, et al.. Practice algorithm for phyllodes tumor: Houston, TX, 2012.
- Albarracin C, Ames F, Andreopoulo E, Araujo D, Arribas E, Arun B, Babiera G, Bast R, Bedrosian I, Benjamin R, et al.. Practice algorithm for phyllodes tumor: Houston, TX, 2011.
- Albarracin C, Ames F, Andreopoulo E, Araujo D, Arribas E, Arun B, Babiera G, Bast R, Bedrosian I, Benjamin R, et al.. Practice algorithm for phyllodes tumor: Houston, TX, 2010.
- Albarracin C, Ames F, Andreopoulo E, Araujo D, Arribas E, Arun B, Babiera G, Bast R, Bedrosian I, Benjamin R, et al.. Practice algorithm for phyllodes tumor: Houston, TX, 2009.
Abstracts
- Adrada BE, Abdelhafez AH, Musall BC, Hess KR, Son JB, Pagel MD, Hwang KP, Candelaria RP, Santiago L, Whitman GJ, Le-Petross H, Moseley TW, Arribas E, Lane DL, Scoggins ME, Spak DA, Leung JWT, Damodaran S, Lim B, Valeo V, White JB, Thompson AM, Litton JK, Moulder SL, Ma J, Yang WT, Rauch GM. Quantitative apparent diffusion coefficient (ADC) radiomics of tumor and peritumoral regions as potential predictors of treatment response to neoadjuvant chemotherapy (NACT) in triple negative breast cancer (TNBC) patients. San Antonio Breast Cancer Symposium, 2019.
- Abdel Hameed AH, Adrada BE, Musall B, Ma J, Candelaria RP, Yang WT, Hess K, Santiago L, Whitman GJ, Le-Petross HC, Moseley TW, Arribas EM, Lane DL, Scoggins ME, Leung JW, Pagel MD, Hwang KP, Son JB, Litton J, Damodaran S, Lim B, White J, Mahmoud HS, Valero V, Thompson A, Moulder S, Rauch GM. Tumor necrosis at baseline dynamic contrast enhanced (DCE) MRI for prediction of neoadjuvant chemotherapy treatment (NACT) response in triple negative breast cancer (TNBC) patients. Radiological Society of North America Scientific Assembly and Annual Meeting, 2019.
- Musall B, Ma J, Adrada BE, Abdel Hameed AH, Candelaria RP, Yang WT, Hess K, Santiago L, Whitman GJ, Le-Petross HC, Moseley TW, Arribas EM, Lane DL, Leung JW, Scoggins ME, Pagel MD, Hwang KP, Son JB, White J, Litton J, Damodaran S, Lim B, Willis B, Mahmoud HS, Megahed AA, Thompson A, S Moulder, Rauch GM. Quantitative tumor volumes by fast dynamic contrast enhanced (DCE) MRI predict pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) in triple negative breast cancer (TNBC). Radiological Society of North America Scientific Assembly and Annual Meeting, 2019.
- Adrada BE, Candelaria RP, Hess K, Moulder S, Santiago L, Valero V, Arribas EM, Moseley TW, Lane DL, Scoggins ME, Le-Petross HC, Spak DA, Huang ML, Litton J, Thompson AM, White J, Whitman GJ, Leung JW, Yang WT, Rauch GM. Precision imaging: Early ultrasound evaluation (US) to identify excellent responders to neoadjuvant chemotherapy (NAC) in patients (pts) with triple negative breast cancer (TNBC). Radiological Society of North America Scientific Assembly and Annual Meeting, 2019.
- Candelaria RP, Hess K, Lane DL, Santiago L, Moulder S, Yang WT, Thompson AM, Rauch GM, Huang ML, Arribas EM, Scoggins ME, Moseley TW, Le-Petross HC, Spak DA, Whitman GJ, Leung JW, Valero V, Damodaran S, Litton J, White J, Adrada BE. Predicting pathologic complete response with ultrasound tumor characteristics in triple negative breast cancer patients. Radiological Society of North America Scientific Assembly and Annual Meeting, 2019.
- Roy M, Sahin AA, Teshome M, Damodaran S, Arribas E , Candelaria R, Albarracin CT, Tetzlaff MT, Curry JL, Aung PP, Torres-Cabala CA, Ivan DS, Prieto VG, Nagarajan P.. Clinically silent male mammary paget disease. The American Society of Dermatopathology 56th Annual Meeting, 2019.